MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2018 International Congress

    Botulinum toxin A (BoNT A) treatment of postsurgical/posttraumatic focal movements not responding to oral therapy

    A. Lozza, A. Castagna, G. Castelnovo, E. Alfonsi, A. Montini, L. Marchetta, M. Fresia, A. Arrigo, R. Manni (Pavia, Italy)

    Objective: We report three cases of focal movement disorder following trauma or surgery. Oral therapies were ineffective in both patients and symptoms dramatically improved after…
  • 2018 International Congress

    Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series

    C. Wang, E. Wang, H. Lei (Tucson, AZ, USA)

    Objective: To report increased risks of Botulinum Toxin Injection for cervical dystonia and migraine in patients with Hypermobility Ehlers Danlos Syndrome. Background: Ehlers-Danlos syndrome (EDS)…
  • 2018 International Congress

    Botulinum toxin in Restless Leg Syndrome – A Randomized Double-Blind Placebo-Controlled Study

    S. Mittal, D. Machado, D. RIchardson, D. Dubey, B. Jabbari (Bangalore, India)

    Objective: To study the efficacy of incobotulinumtoxin A (IncoA) in relieving the symptoms of restless legs syndrome (RLS) Background: RLS is a common movement disorder…
  • 2018 International Congress

    Incobotulinum toxin type A for the treatment of biceps/triceps co-contraction due to obstetrical brachial plexus lesion

    G. Ianieri, R. Marvulli, G. Gallo (Bari, Italy)

    Objective: The injection of Incobotulinum toxin type A associated with physical therapy may improve the kinematics of flexion and extension of the elbow after obstetrical…
  • 2018 International Congress

    Comparison of botulinum toxin injections in forearm flexor and extensor muscles versus pure flexor muscles for the treatment of essential hand tremor (FLEX-D ET)

    S. Patel, X. Yu, J. Lin, O. Hogue, T. Rasameesoraj, D. Hengartner, H. Fernandez (Cleveland, OH, USA)

    Objective: The aim of this study is to compare the efficacy of botulinum toxin (BoNT) injections in forearm flexors and extensor muscles versus pure flexors…
  • 2018 International Congress

    Botulinum toxin injections improve daily life activities in patients with upper limb tremor

    A. Kreisler, B. Bouchain, L. Defebvre (Lille, France)

    Objective: To describe a group of patients with an upper limb tremor refractory to per os medications and receiving Botulinum NeuroToxin type A (BoNT-A) injections.…
  • 2018 International Congress

    Assessing hemifacial spasm: The HFSG scale

    S. Simoni, N. Tambasco, E. Sacchini, E. Marsili, P. Nigro, E. Brahimi, M. Romoli, F. Paolini Paoletti, M. Filidei, P. Calabresi (Perugia, Italy)

    Objective: To create and validate an objective assessing tool to diagnose and monitor HFS and the efficacy of its treatments. Background: Hemifacial spasm (HFS), is…
  • 2017 International Congress

    Palmaris Brevis Spasm:A rare cause of paediatric movement disorder

    T. Yeo, A. Yacoob (Singapore, Singapore)

    Objective: Case report of paediatric Palmaris Brevis Spasm (PBS) Background: PBS is a rare movement disorder causing intermittent twitching of the palmaris brevis muscle. This muscle…
  • 2017 International Congress

    Saliva changes and the oral health in Parkinson´s disease

    J. Tiigimäe-Saar, T. Tamme, P. Taba (Tartu, Estonia)

    Objective: The aim of this study was to determine the risk of change in the oral microflora and oral health in PD patients. Background: Parkinson…
  • 2017 International Congress

    A double-blind, randomized, placebo controlled study of botulinum toxin type A for limb pain in advanced Parkinson’s disease

    V. Bruno, M. Freitas, D. Mancini, J. Liu, J. Miyasaki, S. Fox (CABA, Argentina)

    Objective: To evaluate safety, tolerability and efficacy of botulinum toxin type A for limb pain in advanced Parkinson´s disease (PD). Background: Pain is a frequent…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley